オノニンは,E2F2経由でDNA損傷反応を抑制することによって,パピラリ甲状腺がん細胞をシスプラチンに敏感にします
Xian Deng1,2,3, Xin Qian1, Lian Cheng1
1Department of General Surgery (Thyroid Surgery), The Affiliated Hospital, Southwest Medical University, Luzhou, China, swmu.edu.cn.
International journal of endocrinology
|February 16, 2026
まとめ
オノニンは,DNA損傷の修復を阻害することによって,パピラ性甲状腺がん (PTC) に対するシスプラチンの有効性を高めます. この天然化合物は,E2F2/MDC1経路を標的にし,PTCにおける化学抵抗を克服するための潜在的な戦略を提供します.
科学分野:
- 腫瘍学 腫瘍学
- 分子生物学は分子生物学である.
- 薬理学 薬理学とは
背景:
- papillary thyroid carcinoma (PTC) は,しばしば化学療法に対する耐性を発達させ,治療の有効性を制限する.
- 天然のイソフラボンであるオノニンは抗腫瘍の可能性を示しているが,PTC化学抵抗における役割は未知のものである.
研究 の 目的:
- PTCにおけるシスプラチン感受性に対するオノニンの影響を調査する.
- DNAダメージ応答 (DDR) に焦点を当てて,オノニンの作用の基礎となる分子機構を解明する.
主な方法:
- 利用されたPTC細胞系と,オノニンとシスプラチンが細胞増殖,コロニー形成,上皮-メゼンキマ移行に与える影響を評価した.
- DNAダメージ応答 (DDR) と同型再結合 (HR) の修復経路を調査した.
- E2F2 と MDC1.1 の表現を分析した.
主要な成果:
- オノニンはPTC細胞増殖と上皮-メゼンキマ移行を抑制しました.
- オノニンの前治療はシスプラチンIC50を大幅に低下させ,有効性を高めました.
- オノニンはE2F2をダウン調節し,その後MDC1の発現を低下させ,DNA修復能力を低下させた.
結論:
- オノニンは,E2F2/MDC1軸経由でDDRを弱めることで,PTC細胞をシスプラチンに敏感にします.
- オノニンは,PTCにおけるシスプラチン耐性を克服するための潜在的な補助療法です.
関連する概念動画
02:36DNA Damage Can Stall the Cell Cycle
3.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.2K
02:36DNA Damage can Stall the Cell Cycle
10.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.2K
02:23Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
02:34Inhibition of Cdk Activity
6.0K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
01:23Negative Regulator Molecules
38.6K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.6K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K